Lourdes G. Weltzien Ph.D.
Net Worth
Last updated:
What is Lourdes G. Weltzien Ph.D. net worth?
The estimated net worth of Dr. Lourdes G. Weltzien Ph.D. is at least $5,330,041 as of 15 Feb 2022. He owns shares worth $2,821,141 as insider, has earned $511,920 from insider trading and has received compensation worth at least $1,996,980 in Meridian Bioscience, Inc..
What is the salary of Lourdes G. Weltzien Ph.D.?
Dr. Lourdes G. Weltzien Ph.D. salary is $665,660 per year as Executive Vice President of Life Science Bus. Unit in Meridian Bioscience, Inc..
How old is Lourdes G. Weltzien Ph.D.?
Dr. Lourdes G. Weltzien Ph.D. is 60 years old, born in 1965.
What stocks does Lourdes G. Weltzien Ph.D. currently own?
As insider, Dr. Lourdes G. Weltzien Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Meridian Bioscience, Inc. (VIVO) | Executive Vice President of Life Science Bus. Unit | 83,048 | $33.97 | $2,821,141 |
What does Meridian Bioscience, Inc. do?
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Lourdes G. Weltzien Ph.D. insider trading
Meridian Bioscience, Inc.
Dr. Lourdes G. Weltzien Ph.D. has made only one insider trade in 2022, according to the Form 4 filled with the SEC.
As of 15 Feb 2022 he still owns at least 83,048 units of VIVO stock.
Meridian Bioscience key executives
Meridian Bioscience, Inc. executives and other stock owners filed with the SEC:
- Dr. Lourdes G. Weltzien Ph.D. (60) Executive Vice President of Life Science Bus. Unit
- Mr. John P. Kenny (57) Pres, Chief Executive Officer & Director
- Mr. Tony Serafini-Lamanna (62) Executive Vice President of Diagnostics